Anupam Rasayan India Ltd engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. It operates through two segments: Life Science related Specialty Chemicals and Other Specialty Chemicals. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry; anti-bacterial and ultraviolet protection intermediates and ingredients for the personal care industry; and intermediates and key starting materials for active pharmaceutical ingredients. It provides other specialty chemicals used in various end-user segments, including specialty pigments, specialty dyes, and polymer additives. The company was incorporated in 1984 and is headquartered in Surat, India.
Revenue projections:
Revenue projections for ANURAS Anupam Rasayan India Ltd's revenue projections indicate a decrease from the prior year, which may make investors hesitant. A revenue decline could harm the company's bottom line, prompting investors to be more careful, as lower earnings often signal potential issues with profitability and future performance.
Financial Ratios:
currentRatio
1.423000
forwardPE
50.919285
debtToEquity
44.566000
earningsGrowth
0.447000
revenueGrowth
0.247000
grossMargins
0.579330
operatingMargins
0.227520
trailingEps
8.460000
forwardEps
21.980000
The current ratio for ANURAS is 1.423, indicating that the company can service its short-term debt using available cash and assets. This suggests ANURAS has strong liquidity, with more than enough resources to meet its immediate financial commitments. Anupam Rasayan India Ltd's high forward PE ratio indicates potential overvaluation, which could restrict future price growth and increase the risk of a correction. It's crucial to consider this metric in tandem with other fundamental data to fully assess the stock's outlook. ANURAS's positive growth in earnings and revenue suggests the company is on track to expand its business. These indicators highlight a healthy financial performance, with ANURAS expected to increase its market presence and profitability. Anupam Rasayan India Ltd's positive gross and operating margins reflect its ability to generate profits from operations. These margins demonstrate efficient cost control and profitability, indicating strong financial health for the company. ANURAS's forward EPS is higher than its trailing EPS, which signals that the company is expected to achieve greater profitability this financial year. This suggests improved earnings performance, indicating a positive outlook for ANURAS's financial growth.
Price projections:
Price projections for ANURAS ANURAS's price projections have been revised higher over time, reflecting increased confidence in the company's future potential. This steady upward trend suggests analysts expect ANURAS to continue its positive trajectory.
Recommendation changes over time:
Recommendations trend for ANURAS
Analysts have not provided a clear buy or sell recommendation for Anupam Rasayan India Ltd, painting a mixed picture of the stock's future. Investors may need to rely on a broader range of market insights to determine the best course of action for their portfolios.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
An analysis of why European banks continue to report strong profits despite...
By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our tailored marketing efforts.